PEB - Pacific Edge Ltd

[trader_jackson]

Usually when a company needs to halt trading in their shares due to something in the public domain (what ever that is) it isn't good news...

[LEMON]

Yes but not always. Is there a correction possibly? Been no recent announcement apart from Facey medical

[Minerbarejet]

Perhaps the long awaited payout from CMS for services rendered or conversely confirmation its not coming.
Hope its the former.

[Balance]

The halt has been put in place while PEB drafts a response to information in public domain.

Any ideas...?

Direction of sp in last few days can provide a clue but in this case, nothing conclusive - sp directionless on light volumes since indexing pushed sp up to $1.04 on 19 March.

Sounds to me like there's information being shared in the market which has been brought to PEB's attention for comment and it's material & significant enough to warrant a trading halt.

Could be very positive or very negative - not in-between, I would say!

[trader_jackson]

Usually when a company needs to halt trading in their shares due to something in the public domain (what ever that is) it isn't good news...

https://www.nzx.com/announcements/370436
Sounds like very good news!

[LEMON]

It's very good news.
This will make CX bladder more accessible and allow for more room to move through the medical world I would hope.

[stoploss]

Bit of a worry they took a week to release the announcement .......

[pierre]

Fantastic news for PEB - onwards and upwards from here.

I was a bit worried the Trading Halt might have signified a T/O bid - until I read it. Much too soon for one of those for current shareholders but I wouldn't mind betting there will be a number of US companies with eyes on PEB over the next year or so.

[Leftfield]

https://www.nzx.com/announcements/370436
Sounds like very good news!

Great news!

"Effective from 1 April 2021, Cxbladder is now being covered as a ‘medically necessary bladder tumor marker test’, under United Healthcare’s Molecular Pathology/Molecular Diagnostics/Genetic Testing (Medicare Advantage) - Medical Policy.

United Healthcare has over 50 million members with more than 5.7 million Medicare Advantage members. In 2019, UnitedHealth Group had a 14.1 percent share of the U.S. health insurance market, with direct premiums written amounting to approximately US$107 billion . The organisation partners with 6,500 hospitals and care facilities nationwide, and more than 1.3 million physicians and other providers."

[kerryo]

Sharemarket likes it.